日本語
TOP page
Published papers
Academic conference presentation
Education
(Last updated : 2024-11-05 17:54:48)
Satou Takatoshi
Department
School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Pediatrics
Position
Assistant Professor
■
Published papers
1.
Original article
Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy. 2021/03
2.
Review article
A short form of gross motor function measure for Fukuyama congenital muscular dystrophy 2020/05
3.
Original article
The gross motor function measure is valid for Fukuyama congenital muscular dystrophy. 2017/01
4.
Original article
Respiratory management of patients with Fukuyama congenital muscular dystrophy. 2016/03
5.
Original article
DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions. 2013/03
6.
Original article
福山型先天性筋ジストロフィーにおける不眠の検討(Insomnia in Patients with Fukuyama Congenital Muscular Dystrophy) 2013/01
7.
Case report
National registry of patients with Fukuyama congenital muscular dystrophy in Japan. 2018/10
8.
Original article
Characteristic findings of skeletal muscle MRI in caveolinopathies. 2018/10
9.
Case report
GNAO1
-Related Disorder in a Patient with Psychomotor Developmental Delay and Hypotonia 2022/04/25
10.
Original article
Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy. 2021/12/20
Display 5 items
Display all(10)
■
Academic conference presentation
1.
A novel RYR1 variant in a congenital myopathy patient is associated with autosomal recessive trait 2024/10/12
2.
Study of upper limb function using Bioelectrical impedance analysis in Fukuyama congenital muscular dystrophy 2024/06/01
3.
Survey of COVID-19-affected neuromuscular disease patients in Japan 2024/05/30
4.
Complications in patients with congenital myotonic dystrophy: data from a nationwide myotonic dystrophy registry. 2024/04/10
5.
Juvenile Dermatomyositis with Interstitial Lung Disease after COVID-19: A Case Report. 2024/03/15
6.
Study of dysphagia in Fukuyama congenital muscular dystrophy (FCMD) 2023/10/06
7.
Sleep disorders in Fukuyama congenital muscular distrophy 2023/05/27
8.
Study of dysphagia in Fukoyama congenital muscular dystrophy (FCMD) 2023/05/27
9.
A boy with novel ACAD9 variant presenting hypertrophic cardiomyopathy, muscle weakness and exercise-intolerance 2023/05/26
10.
Long-term follow-up of skeletal muscle imaging in patients with childhood-onset Pompe disease 2023/05/26
11.
Muscle imaging in pediatric myogenic diseases 2023/05/24
12.
A boy with spondylodiscitis complicated with epidural abscess induced by exercise 2023/04/16
13.
Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy 2023/04/16
14.
Two infantile patients with pseudohypoaldosteronism assoiated with congenital anomalies of the kidney and urinary tract 2023/04/16
15.
Consideration on the severity of central nervous system and muscular disorders caused by HECW2 mutation 2022/12/17
16.
Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy 2022/10/14
17.
Characteristics of cardiac dysfunction in patients with Fukuyama congenital muscular dystrophy 2022/06/03
18.
Correlation between BNP and NT-proBNP in muscular dystrophy (Second report) 2022/06/03
19.
Family association questionnaire on "unmanageable troubled behaviors” in patients with FCMD 2022/06/03
20.
Nationwide survey of medical care situations for myotonic dystrophy in Japan 2021/08/28
21.
A symptomatic female MTM1 mutation carrier with right-dominant asymmetric muscle weakness 2021/05/29
22.
Correlation between BNP and NT-proBNP in muscular dystrophy 2021/05/28
23.
Evaluation of essential trace elements in patients with Fukuyama congenital muscle dystrophy 2021/05/28
24.
Nationwide survey of medical care situations for myotonic dystrophy in Japan 2021/05/28
25.
A case of chondrodysplasia punctate patient requiring differentiation of floppy infant 2020/08/19
26.
Actigraphy is valid for motor function assessment of Fukuyama congenital muscular dystrophy 2020/08/19
27.
Considering diagnostic announcement by a survey for parents of myotonic dystrophy patients 2020/08/19
28.
Efficacy evaluation of Nusinersen for spinal muscular atrophy type 1/2 using bioelectrical impedance 2020/08/19
29.
Complications of Fukuyama congenital muscular dystrophy revealed from a nationwide registry 2019/10/04
30.
Urinary titin fragment in Fukuyama congenital muscular dystrophy 2019/10/04
31.
A questionnaire for parents about raising children with congenital/childhood-onset myotonic dystrophy in Japan 2019/10/02
32.
Characteristic findings of skeletal muscle MRI in Cavecolinopathies 2019/10/02
33.
Characteristic skeletal muscle imuscle imaging patterns in Japanese patients with Pompe disease 2019/07/13
34.
Characteristic findings of skeletal muscle MRI in childhood-onset Cavecolinopathy 2019/06/01
35.
A questionnarvey of intellectual development in Fukuyama congenital muscular dystrophy 2019/05/31
36.
Efficacy of corticosteroids therapy for Fukuyama congenital muscular dystrophy 2019/05/31
37.
Urinary titin fragment in Fukuyama congenital muscular dystrophy 2019/05/31
38.
The effectiveness of nusinersen in 3 patients with spinal muscular atrophy type I receiving TPPV 2018/06/02
39.
Care and prevention of foot disorders in Bethelm myopathy patients 2018/06/01
40.
Early diagnosis and prompt initiation of enzyme replacement therapy in a 1-year-old girl with Pompe disease 2018/06/01
41.
Modified gross motor function measure for Fukuyama congenital muscular dystrophy 2018/05/31
42.
The questionnaire survey about the process and the notice of diagnosis for the FCMD patient's family 2018/05/31
43.
Time-dependent change of Musce MRI STIR in Fukuyama congenital muscular dystrophy 2017/10/14
44.
A Japanese nationwide survey on congenital myotonic dystrophy 2017/05/13
45.
Japanese nationwide registry for Fukuyama congenital muscular dystrophy patients study 2017/05/13
46.
Relationship between inpedance obtained by BIA and MR Images of limbs of patients with Fukuyama congenital muscular dystrophy 2017/05/13
47.
The gross motor function measure is valid for Fukuyama congenital muscular dystrophy 2017/05/13
48.
Correlation between MRI STIR image of lower limbs and BIA in the natural course of FCMD patients 2016/06/03
49.
Nationwide patient registry of Fukuyama congenital muscular dystrophy in Japan 2016/06/03
50.
Our approach which aimed at ideal transition for muscular dystrophy patients to adult health care 2016/06/03
51.
The gross motor function measure is a valid for Fukuyama congenital muscular dystrophy 2016/06/03
52.
Time-dependent change of Muscle MRI STIR in Fukuyama congenital muscular dystrophy 2016/06/03
53.
Effectiveness of levetiracetam for seizures in patients with Fukuyama congenital muscular dystrophy 2014/10/09
54.
Natural history of motor function in patients with Fukuyama congenital muscular dystrophy 2014/10/09
55.
Renal dysfunction in patients with Fukuyama congenital muscular dystrophy 2014/10/09
56.
A new index of muscle development and disease progression for the pediatric patients with Duchenne muscular dystrophy, using bioelectrical impedance analysis: An observation study 2014/10/08
57.
A new index of muscle development and disease progression for the pediatric patients with Fukuyama congenital muscular dystrophy, using bioelectrical impedance analysis; an observation study 2014/10/08
58.
Skeletal muscle MRI in an X-linked myotubular myopathy patient who became ambulatory 2014/10/07
59.
Skeletal muscle MRI with fat suppression technique can detect early changes in childhood onset Pompe disease in patients receiving ERT 2014/09/27
60.
Chronic respiratory failure in patients with Fukuyama congenital muscular dystrophy 2013/10/02
61.
Steroid Treatment for exacerbation of muscle weakness after viral infection in Fukuyama congenital muscular dystrophy 2013/10/02
62.
Therapeutic intervention for dysphagia in patients with Fukuyama congenital muscular dystrophy 2013/10/02
Display 5 items
Display all(62)
■
Education
1.
2009/04~2013/01
〔Doctoral course〕 Pediatrics, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed, Doctor of Philosophy